Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-1447.7%Return on Equity
VS
Market
Sector
Industry
History
$ 1.72Close
$ 1.15 - $ 5.82 52-Week Range
Ticker Information
Ticker
HUMACompany Name
HUMACYTE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQHUMACYTE INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
HUMA - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 4.05M | $ -58.66M | -1447.7% |
| 3/31/2025 | $ 36.04M | $ -77.67M | -215.48% |
| 12/31/2024 | $ -52.67M | $ -148.7M | 0% |
| 9/30/2024 | $ -63.72M | $ -152.87M | 0% |
| 6/30/2024 | $ -28.29M | $ -139.66M | 0% |
| 3/31/2024 | $ 26.15M | $ -105.7M | -404.19% |
| 12/31/2023 | $ 13.55M | $ -110.78M | -817.78% |
| 9/30/2023 | $ 36.99M | $ -89.39M | -241.64% |
| 6/30/2023 | $ 61.12M | $ -88.68M | -145.09% |
| 3/31/2023 | $ 81.89M | $ -29.1M | -35.54% |
Key Performance Insights, Last 5 Years
- HUMACYTE INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, HUMACYTE INC's average ROE has been -246.87%.
- The median ROE for HUMACYTE INC during this period was -85.65%
- HUMACYTE INC reached its highest ROE over the past 5 years at 28.94%.
- The lowest ROE recorded by HUMACYTE INC in the same timeframe -1447.7%
HUMACYTE INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for HUMACYTE INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 5M ]
(=) ROE [ 0% ] HUMA - Return on Equity, Last 5 years
-1447.7%
Minimum
Jun 30, 2025
28.94%
Maximum
Sep 30, 2022
-246.87%
Average
-85.65%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |